Literature DB >> 2454292

Molecular biology of myelin proteins from the central nervous system.

A T Campagnoni1.   

Abstract

Within the past several years, several of the genes coding for the major myelin proteins have been isolated, characterized, and mapped to specific chromosomes. In all cases, it has been clearly established that these proteins exist as multiple isoforms, and their structures have been established through an analysis of the cDNA clones encoding them. In each case, the isoforms appear to arise through the translation of individual mRNAs produced by alternative splicing of the primary transcript of a single gene. In several cases, the expression of the individual isoforms appears to be developmentally and/or regionally regulated, probably at the level of the splicing of the primary transcript. In the case of the dysmyelinating mutants shiverer and jimpy, the molecular defects involve the MBP gene and PLP gene, respectively; most of the dysmyelinating mutants, including those in which the genetic defect is established, appear to exhibit pleiotropy with respect to the expression of other myelin protein genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454292     DOI: 10.1111/j.1471-4159.1988.tb04827.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  43 in total

1.  A transgenic mouse model for inducible and reversible dysmyelination.

Authors:  C Mathis; C Hindelang; M LeMeur; E Borrelli
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Myelin and myelinization in the telencephalon and mesencephalon of the lizard Gallotia galloti as revealed by the immunohistochemical localization of myelin basic protein.

Authors:  C Yanes; M Monzon-Mayor; J de Barry; G Gombos
Journal:  Anat Embryol (Berl)       Date:  1992

3.  Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes.

Authors:  Audrey D Lafrenaye; Babette Fuss
Journal:  J Neurochem       Date:  2010-08-19       Impact factor: 5.372

4.  Evidence that the homeodomain protein Gtx is involved in the regulation of oligodendrocyte myelination.

Authors:  R Awatramani; S Scherer; J Grinspan; E Collarini; R Skoff; D O'Hagan; J Garbern; J Kamholz
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

5.  Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals.

Authors:  Ryan P Bell; John J Foxe; Jay Nierenberg; Matthew J Hoptman; Hugh Garavan
Journal:  Drug Alcohol Depend       Date:  2010-11-13       Impact factor: 4.492

6.  Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy.

Authors:  Andrew C Eschenroeder; Allison A Vestal-Laborde; Emilse S Sanchez; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2011-10-14       Impact factor: 7.452

7.  T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis.

Authors:  Sara Abromson-Leeman; Rod Bronson; Yi Luo; Michael Berman; Rebecca Leeman; Joshua Leeman; Martin Dorf
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

8.  Expression of transcripts for myelin related genes in postmortem brain from cocaine abusers.

Authors:  Lars V Kristiansen; Michael J Bannon; James H Meador-Woodruff
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

9.  Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain.

Authors:  Emilse S Sanchez; John W Bigbee; Wambura Fobbs; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2008-07       Impact factor: 7.452

10.  Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro.

Authors:  Fatiha Radja; Denis G Kay; Steffen Albrecht; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.